Month: May 2013

Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data

Theresa A. Cassidy, MPH, Emily C. McNaughton, MPH , Kimberly Lobo, MPH , Simon H. Budman, PhD, Stephen F. Butler, PhD Presented at American Society of Addiction Medicine (ASAM), Chicago, IL, April 25-27th, 2013  See our poster for “Abuse of Reformulated OPANA® ER: early findings from NAVIPPRO® data” here Abstract Summary: Reformulated extended release (ER) oxymorphone (OPANA… Read more »

How does use of a prescription monitoring program change pharmacy practice?

Based on a recent study, our team has published an article in “Journal of the American Pharmacists Association” titled, “How does use of a prescription monitoring program change pharmacy practice?” To access the full text, click here.  Abstract Objectives To assess differences in prescription monitoring program (PMP) use between two states with different PMP accessibility… Read more »